95251
Continuous Glucose Monitoring Analysis and Interpretation
CPT code 95251 describes the professional work involved in the analysis and interpretation of data recorded by a continuous glucose monitoring (CGM) system. This procedure involves a physician or qualified healthcare professional reviewing at least 72 hours of glucose data collected from the patient's interstitial fluid via a subcutaneous sensor. Unlike the technical component (CPT 95250), which involves the actual hook-up and sensor calibration, 95251 is strictly for the intellectual work of interpreting the results. The provider must download the stored data and meticulously review glucose trends, including mean glucose levels, glycemic variability, and the percentage of time spent within, above, or below target ranges (Time in Range). The analysis includes identifying patterns such as postprandial spikes, nocturnal hypoglycemia, or the 'dawn phenomenon.' Crucial to this code is the correlation of glucose fluctuations with the patient's daily logs, which record carbohydrate intake, physical activity, medication or insulin dosing, and stressful events. The provider uses these insights to make informed adjustments to the patient's diabetes management plan, which may include altering insulin pump settings, changing oral hypoglycemic agents, or providing nutritional counseling. A formal, written report must be generated and stored in the medical record, documenting the data findings, the provider’s clinical interpretation, and the specific therapeutic recommendations or changes made to the patient's care plan.
Clinical Indications
- Type 1 Diabetes Mellitus with glycemic instability
- Type 2 Diabetes Mellitus with frequent episodes of hypoglycemia
- Gestational Diabetes requiring insulin management
- Hypoglycemic unawareness where the patient does not feel symptoms of low blood sugar
- Recurrent ketoacidosis or hyperglycemic hyperosmolar state
- Poor glycemic control despite adherence to a multi-dose insulin regimen
- Evaluation of the Somogyi effect or dawn phenomenon
- Transitioning a patient to an insulin pump or an automated insulin delivery system
- Pediatric patients with diabetes needing intensive monitoring
- Monitoring glucose variability in patients with cystic fibrosis-related diabetes
Procedure Steps
- Download or retrieve the glucose data from the CGM device or the manufacturer's cloud-based platform.
- Verify that a minimum of 72 hours of continuous glucose data has been captured.
- Examine the glucose traces and summary statistics, such as Average Glucose and Glucose Management Indicator (GMI).
- Review the patient's diary or digital log to correlate glucose excursions with meals, insulin doses, and exercise.
- Identify specific patterns of glycemic instability, such as frequent nocturnal lows or persistent afternoon highs.
- Determine the Coefficient of Variation (CV) to assess the degree of glycemic variability.
- Formulate adjustments to the treatment regimen, such as basal insulin titration or bolus ratio changes.
- Generate a comprehensive written report detailing the analysis, findings, and the resulting clinical plan.
Coding Guidelines
- 95251 is for the professional component (interpretation and report) only.
- The service may be reported no more than once per month (30 days).
- A minimum of 72 hours of sensor data must be available for analysis to report this code.
- Do not report 95251 in conjunction with 95249 or 95250 if the same provider is performing only the interpretation on the same day as the hook-up (refer to specific payer bundling rules).
- A written report must be completed and signed by the interpreting physician or qualified healthcare professional.
- 95251 can be reported for both 'Professional CGM' (clinic-owned device) and 'Personal CGM' (patient-owned device).
- If performed on the same day as an E/M visit, ensure the E/M service is distinct and append modifier 25 if necessary, though some payers consider the interpretation part of the MDM for the E/M.
Associated ICD-10 Codes
- E10.9 - Type 1 diabetes mellitus without complications
- E11.9 - Type 2 diabetes mellitus without complications
- E10.65 - Type 1 diabetes mellitus with hyperglycemia
- E11.65 - Type 2 diabetes mellitus with hyperglycemia
- E10.649 - Type 1 diabetes mellitus with hypoglycemia without coma
- E11.649 - Type 2 diabetes mellitus with hypoglycemia without coma
- E16.2 - Hypoglycemia, unspecified
- O24.410 - Gestational diabetes mellitus in pregnancy, diet-controlled
- O24.414 - Gestational diabetes mellitus in pregnancy, insulin-controlled
- E10.10 - Type 1 diabetes mellitus with ketoacidosis without coma